额头缺席发作的流行病学和临床特征与主要缺席发作相比
J M Ramos-Fernández1, A Extraviz Moreno2, N Del Arco Guzmán2
1Grupo de Investigación IBIMA, Sección de Neurología Pediátrica, Servicio de Pediatría, Hospital Regional de Málaga, Avda. arroyo de los Ángeles sn, 29010, Málaga, Spain.
Neurologia
|November 23, 2025
概括
额头缺席 (FAE) 是童年缺席 (AE) 的重要组成部分,与初级缺席 (PAE) 相似,但每日发作较少,治疗反应较差.
科学领域:
- 儿科神经学 儿科神经学
- 的研究研究.
- 临床神经生理学 临床神经生理学
背景情况:
- 缺席发作 (AE) 可能源于额叶起源 (FAE),模仿初级缺席 (PAE).
- 由于预后和治疗策略不同,区分FAE和PAE至关重要.
- 关于儿童FAE的流行病学数据仍然有限.
研究的目的:
- 为了调查儿童FAE的流行病学.
- 为了比较FAE与PAE在临床特征,疾病进展和对抗药物的反应方面.
- 增强对FAE患病率和儿科的临床概况的理解.
主要方法:
- 从2013年到2022年,在第三级医院对儿科AE病例 (14岁以下) 的回顾性分析.
- 对人口统计数据,发作类型,EEG发现 (包括前部焦点),治疗反应和神经影像进行比较研究.
- 统计分析以确定FAE和PAE组之间的差异.
主要成果:
- 分析了94名患有AE的儿童;14.8%的儿童表现出一般性放出之前的额头焦点.
- 每天FAE病例的缺席发作显著减少 (p=0.004).
- 在FAE (p=0.005双变量,p=0.035多变量) 中观察到对组合治疗的更大需求.
结论:
- 额头缺席 (FAE) 占童年缺席 (AE) 的显著比例.
- FAE与PAE具有形态和时间特征,但发作频率降低.
- 与PAE相比,FAE对药物治疗的反应不太好.
相关概念视频
01:13Seizures: Classification
1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
01:24Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
799
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
799
01:20Antiepileptic Drugs: Potassium Channel Activators
613
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
613